What was LAUNXP BIOMEDICAL CO., LTD.’s price range in the past 12 months?
LAUNXP BIOMEDICAL CO., LTD. lowest stock price was TWD 9.09 and its highest was TWD 25.45 in the past 12 months.
What is LAUNXP BIOMEDICAL CO., LTD.’s market cap?
LAUNXP BIOMEDICAL CO., LTD.’s market cap is TWD 888.66M.
When is LAUNXP BIOMEDICAL CO., LTD.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is LAUNXP BIOMEDICAL CO., LTD. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does LAUNXP BIOMEDICAL CO., LTD. pay dividends?
LAUNXP BIOMEDICAL CO., LTD. does not currently pay dividends.
What is LAUNXP BIOMEDICAL CO., LTD.’s EPS estimate?
LAUNXP BIOMEDICAL CO., LTD.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LAUNXP BIOMEDICAL CO., LTD. have?
LAUNXP BIOMEDICAL CO., LTD. has 70,528,540 shares outstanding.
Which hedge fund is a major shareholder of LAUNXP BIOMEDICAL CO., LTD.?
Currently, no hedge funds are holding shares in TW:6876
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
LAUNXP BIOMEDICAL CO., LTD.
LAUNXP Biomedical Co. Ltd. specializes in developing innovative pharmaceutical treatments for various types of cancer. Their product line includes therapies designed to combat tumor growth and inhibit cell proliferation, notably utilizing advanced platforms such as virus-like nanoparticles and other nanoparticle-based drug delivery systems. The company was established on September 24, 2015, and its primary corporate operations are based in Taichung, Taiwan.